Ansa Biotechnologies
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
Y Combinator
yc-company-directory #4196Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
sourceAnsa Biotechnologies is classified as Healthcare from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Ansa Biotechnologies
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Ligo Biosciences
match 61We are building the next generation of deep-learning models for enzyme design to slash the cost of chemical manufacturing. The $6 trillion chemical industry is flawed: It produces 20% of industrial greenhouse gases, and is responsible for 15% of global energy usage. Enzymes offer a far more sustainable alternative to chemical synthesis and have already revolutionised how a select few chemicals are produced. The problem is each enzyme takes years of trial and error to develop. Our enzyme models l
shared extracted concept terms: enzyme, chemical; shared product terms: develop, manufactur, chemical, year; shared affiliation: Y Combinator
Atomic Alchemy
match 56Atomic Alchemy is building a bank of reactors to produce the nuclear material that goes into nuclear medicine. Radiopharmaceuticals are vitally important in biological tracers, diagnostic imaging, and cancer treatments. Currently, the world's supply of Molybdenum-99, the cornerstone of 80% of all nuclear medicine procedures, is sourced from just six government-run, scientific research reactors abroad. Five of these reactors are 45-65 years old and are quickly coming to the end of their operation
shared extracted concept terms: diagnostic; shared product terms: currently, year, biological, research; shared product theme: health and clinical care; shared affiliation: Y Combinator
Lygos
match 48Founded in 2010, Lygos is providing biotechnology solutions for today’s renewable chemical challenges. They engineer microbes to convert sugars into high-value, industrial chemicals, targeting compounds where biological production is cost-advantaged over petrochemical production.
shared extracted concept terms: biotechnology, chemical; shared product terms: chemical, biological, biotechnology; same category: Healthcare; shared affiliation: Y Combinator
Correlia Biosystems
match 48Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.
shared extracted concept terms: diagnostic; shared product terms: develop, accelerate, biological, diagnostic; shared product theme: health and clinical care; shared affiliation: Y Combinator
Yemaachi Biotechnology
match 41Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kin
shared product terms: exist, research, therapeutic, diagnostic; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator
Future Fields
match 38Future Fields has developed the world's first multicellular advanced biomanufacturing platform for the production of the most challenging recombinant proteins. We help companies in biotech, life sciences, and pharma by manufacturing their proteins.
shared extracted concept terms: biomanufactur; shared product terms: develop, manufactur, biomanufactur; same category: Healthcare; shared affiliation: Y Combinator